Mushroom Tea For Use In Psychedelic Research Developed By Numinus Wellness
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and evidence-based psychedeli
Ketamine for Parkinson’s Disease, PharmaTher Holdings Announces Grant of U.S. Patent To Cover It
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM), a pharmaceutical company focused on developing novel uses and delivery forms of ketamine
Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S.
EXCLUSIVE: atai’s Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing
Clinical-stage biopharma company atai Life Sciences N.V. (NASDAQ: ATAI) has commenced dosing volunteers for its ongoing Phase 1 clinical study investigating its proprietary DMT-based VLS-01 for treatment-resistant depression (TRD).
Zappy Zapolin Of Psycheceutical Bioscience Joins The Benzinga Psychedelics Advisory Council: What You Need To Know
Zappy Zapolin, Chief Visionary Officer at Psycheceutical Bioscience, Inc.
Justice Dept Grants $1M To Non-Profits To Help Stem Teen Mental Health Issues & School Violence
A silent epidemic is moving across the country. Each year, from one in five children in the U.S., show signs or symptoms of a mental health disorder, be it depression, anxiety or substance abuse.
Can Ketamine Treat Alcohol Addiction? This Is How Therapy Actually Functions
(Part two of a four-part series, see part one here)
Psyched: Autopsy Reveals Death By Ketamine, LSD-Like Drugs Without Hallucinations, DEA & Right To Try Psilocybin
Amended Autopsy Confirms Elijah McClain Died From Ketamine Injected By Paramedics Called By Cops
Irwin Naturals Acquires Ketamine Media, Nation’s Leading Platform For Ketamine Clinics
Irwin Naturals Inc. (OTC: IWINF) is expanding its efforts in offering ketamine-assisted therapy to those in need.
